These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 20049841)

  • 41. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
    Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
    Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1.
    Jin L; Datta PK
    Cell Cycle; 2014; 13(24):3909-20. PubMed ID: 25483064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
    Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A
    Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of STAT1-Driven Transcriptional Activity by Histone Deacetylases.
    Owusu BY; Klampfer L
    Methods Mol Biol; 2017; 1510():277-285. PubMed ID: 27761828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
    Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
    Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
    Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
    Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Converse role of class I and class IIa HDACs in the progression of atrial fibrillation.
    Zhang D; Hu X; Li J; Hoogstra-Berends F; Zhuang Q; Esteban MA; de Groot N; Henning RH; Brundel BJJM
    J Mol Cell Cardiol; 2018 Dec; 125():39-49. PubMed ID: 30321539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
    Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
    Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of siRNA targeting HDAC1 gene on proliferation, apoptosis, histone acetylation, and histone methylation in gastric cancer cells in vitro].
    Zhuang H; Ma X; Lai Y; Xu X; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):246-50. PubMed ID: 24589606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identifying targets for the restoration and reactivation of BRM.
    Kahali B; Gramling SJ; Marquez SB; Thompson K; Lu L; Reisman D
    Oncogene; 2014 Jan; 33(5):653-64. PubMed ID: 23524580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas.
    Weichert W; Denkert C; Noske A; Darb-Esfahani S; Dietel M; Kalloger SE; Huntsman DG; Köbel M
    Neoplasia; 2008 Sep; 10(9):1021-7. PubMed ID: 18714364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of novel isoform-selective inhibitors within class I histone deacetylases.
    Hu E; Dul E; Sung CM; Chen Z; Kirkpatrick R; Zhang GF; Johanson K; Liu R; Lago A; Hofmann G; Macarron R; de los Frailes M; Perez P; Krawiec J; Winkler J; Jaye M
    J Pharmacol Exp Ther; 2003 Nov; 307(2):720-8. PubMed ID: 12975486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer.
    Park SY; Jun JA; Jeong KJ; Heo HJ; Sohn JS; Lee HY; Park CG; Kang J
    Oncol Rep; 2011 Jun; 25(6):1677-81. PubMed ID: 21455583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gender-dependent histone deacetylases injury may contribute to differences in liver recovery rates of male and female mice.
    Wang Y; Ye F; Ke Q; Wu Q; Yang R; Bu H
    Transplant Proc; 2013 Mar; 45(2):463-73. PubMed ID: 23498780
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drosophila histone deacetylase-3 controls imaginal disc size through suppression of apoptosis.
    Zhu CC; Bornemann DJ; Zhitomirsky D; Miller EL; O'Connor MB; Simon JA
    PLoS Genet; 2008 Feb; 4(2):e1000009. PubMed ID: 18454196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
    Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
    Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HDAC1 and HDAC2 regulate anti-inflammatory effects of anesthetic isoflurane in human monocytes.
    Guo X; Deng J; Zheng B; Liu H; Zhang Y; Ying Y; Jia J; Ruan X
    Immunol Cell Biol; 2020 Apr; 98(4):318-331. PubMed ID: 31950542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression.
    Zeng H; Zhang JM; Du Y; Wang J; Ren Y; Li M; Li H; Cai Z; Chu Q; Yang C
    Oncotarget; 2016 Feb; 7(6):7329-42. PubMed ID: 26797758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated immunoreactivity against class I histone deacetylases in adenomyosis.
    Liu X; Nie J; Guo SW
    Gynecol Obstet Invest; 2012; 74(1):50-5. PubMed ID: 22539030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.